Insilico Medicine
Saudi Arabia·Middle East
Aramco-backed Prosperity7 Ventures led an investment bringing Insilico Medicine's Series D to US$95M (10 Aug 2022); Insilico uses generative AI for drug discovery.
Deployment Intelligence
Each record carries country, segment, entry mode, local partner and verbatim scale wording, with a public source link wherever one exists. Check the original source before citing it in a business case, due-diligence answer or board briefing.
How to read these numbers: A purposive, publicly sourced case library, not a probability sample: counts describe the library, not market share. Monetary figures mix investment, revenue and user metrics — treat them as magnitude markers and defer to the verbatim description and source link.
Source: platform database (market_deployments).
2 matching records — showing 1–2
Saudi Arabia·Middle East
Aramco-backed Prosperity7 Ventures led an investment bringing Insilico Medicine's Series D to US$95M (10 Aug 2022); Insilico uses generative AI for drug discovery.
Saudi Arabia·Middle East
At Arab Health 2025 (Feb 2025) United Imaging announced a multi-disciplinary collaboration with Saudi Arabia's Al Mana Group spanning CT, radiotherapy, molecular imaging and AI, delivered via its uAI platform (AI-assisted reconstruction/diagnosis).